The problem and solution

A Widespread Problem with Limited Solutions

4 out of 5 people struggle with speech and myofunctional disorders, impacting their communication, confidence, and overall health. Traditional treatments are time and travel intensive.

The Market Opportunity

The OMD’s market presents a significant opportunity for growth, as highlighted by the projected evolution from 2025 to 2028.

In 2025, the:

Total Addressable Market (TAM) evaluated at 305 million cases

Serviceable Available Market (SAM) is evaluated at 305,000 cases

Serviceable Obtainable Market (SOM) is evaluated at 2,000 cases

By 2028 these numbers are projected to grow significantly:

TAM increases slightly to over 300 millon estimated cases

SAM will be expaned to over 1.8 millon cases

SOM experiences a massive jump expected to 54,000 cases

The growing number of cases is due to the overall market growth, the aspiration of CODONIS to do geographic expansions and product diversifications but also to the increasing patient and consumer spending power.

The Market Opportunity – Estimated Value

The treatment of orofacial myofunctional disorders (OMDs), speech disorders, paresis, and cleft/palate conditions represents a significant and growing economic opportunity in the healthcare sector.

OMDs
(majority of cases)

CHF 1,500 per treatment
(based on 10 sessions)

Speech Disorders
(~15% of cases)

CHF 1,500 per treatment
(based on 10 sessions)

Paresis
(1–5% of cases)

CHF >20K
(includes therapy and surgery)

Cleft/Palate
(0.1–1% of cases)

CHF >20K
(includes therapy and surgery)

Market Size Projections

YearTAM (Total Addressable Market)SAM (Serviceable Available Market)SOM (Serviceable Obtainable Market)
2024USD 37.6 bnUSD 3.76 bnUSD 5.3 mn 
2030USD 63.8 bnUSD 6.38 bnUSD 31.9 mn (based on 2% EU SAM)

Key highlights:

  • In 2024, the SOM is valued at USD 5.3 million.
  • By 2030, the SOM grows substantially to USD 31.9 million, signaling a strong market capture potential over six years, especially within the European segment of the speech therapy market.
SegmentSOM Value (USD)% Allocation (suggested)
OMD incl. BeautyUSD 12.8 million40% (Face yoga, aesthetics)
Speech DisordersUSD 10.0 million31% (Clinical therapy focus)
Paresis (Facial)USD 6.4 million20% (Facial palsy, etc.)
Cleft/PalateUSD 2.7 million9% (Smaller but critical)

 

With increasing awareness, technological advancements, and improved access to therapy, this market holds significant untapped potential—particularly as CODONIS scales its services across the EU and North America.

The CODONIVERSE

Discover innovative solutions tailored to enhance your orofacial & myofunctional health and well-being

CODONIS ONE 3D View

An orofacial myofunctional training system for smart speech therapy. Your path to a natural smile! 

CODONIS ORB 3D View

An orofacial myofunctional therapy device for the stimulation and strengthening of the orofacial muscles.

Where We're Investing

Our Strategic Focus Areas for Innovation and Growth

Device Smartification

Integrating intelligent sensors and connectivity into our therapy devices to provide real-time data and personalized feedback, optimizing patient outcomes.

Multivariable Data Analysis

Developing advanced analytics to
process and interpret patient data,
enabling predictive insights and
customized therapy plans and motivating patients.

Gamification

Designing interactive and
rewarding therapy experiences that
increase patient engagement and
promote long-term adherence

CODONIS in numbers

Driving measurable impact through innovation and care

Trained Therapists
0 +
Succesful Treatments
0 +
Active Therapies
0 +
Products
0

Real People, Real Success Stories

Driving measurable impact through innovation and care

Testimonials

See what people say about us

The team behind CODONIS

At CODONIS AG, our team brings together a wealth of knowledge and experience. Led by CEO Susanne Codoni, alongside Dr. Stefan Stübinger, Fabio Cirillo, Michael Hug and Marlène Linder Lovis, we collectively possess close to a century of expertise in speech therapy, dental diseases, and device development within this discipline.

Dr.h.c Susanne Codoni

Susanne is a dedicated speech therapist and a therapeutic expert who breaks new ground and makes a significant contribution to improving the quality of life of her clients through her innovative way of thinking and tireless commitment. She is a driving force in myofunctional therapy and is committed to making the impossible possible.

PD Dr. Stefan Stübinger

Stefan is our clinical & dental expert and has so many ideas for dental applications that even the dentist's chair is shaking with creativity.

Fabio Cirillo

Fabio is a master at turning ideas into reality, with a deep understanding of requirements, quality and engineering. His foresight guarantees that everything not only works today, but is also strategically resourceful and a perfect fit for the future

Michael Hug

Michael, with his solid dental background, is the man who seamlessly implements ideas from development to go-to-market. With his keen eye for detail and his innovative strength, he successfully brings new concepts to market

Marlène Linder Lovis

Marlène is a trainer in myofunctional therapy and is characterized by her francophone ease and methodical approach. Her well-founded contributions and ability to convey complex concepts in an understandable way contribute significantly to the further development of her colleagues' and clients' work.

CODONIS Active Therapists

Discover trusted locations with CODONIS-trained therapist where you can receive CODONIS product prescriptions.

Our Premium Partners

Ready to join the future?
Contact CODONIS

Get the info you’re looking for right now.

Or Book a Call

Get in touch directly with our team for more information